STILBETIN vs TOLAK

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. STILBETIN and TOLAK are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	STILBETIN	TOLAK
Rating	72/100	72/100
Pharmacy pays	—	$0.61 /mL
Type	RX	RX
Active ingredient	DIETHYLSTILBESTROL	FLUOROURACIL
Manufacturer	Bristol Myers Squibb	Hill Dermaceuticals
Dosage forms	Tablet, Tablet, delayed release	Topical
Drug class	—	Nucleoside Metabolic Inhibitor
Boxed warning	None	None
Treats	Breast Neoplasms, Carcinoma, Prostatic Neoplasms	Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

stilbetin tolak

Rating

72/100

Pharmacy pays

—

$0.61 /mL

Type

Active ingredient

DIETHYLSTILBESTROL

FLUOROURACIL

Manufacturer

Bristol Myers Squibb

Hill Dermaceuticals

Dosage forms

Tablet, Tablet, delayed release

Topical

Drug class

—

Nucleoside Metabolic Inhibitor

Boxed warning

None

Treats

Breast Neoplasms, Carcinoma, Prostatic Neoplasms

Breast Neoplasms, Basal Cell Carcinoma, Colonic Neoplasms

Frequently asked questions

Which is better-rated, Stilbetin or Tolak?

Stilbetin and Tolak are tied at 3.6 out of 5 by our independent rating.

What is the difference between Stilbetin and Tolak?

Stilbetin contains Diethylstilbestrol, while Tolak contains Fluorouracil — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.